EcoDrugPlus

Ribosomal Protein S3

Ensembl ID : ENSEBUG00000003683
Gene Symbol: RPS3
1 Cross references
530 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSEBUG00000008049
Gene Symbol: RPS5
1 Cross references
261 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSEBUG00000011539
Gene Symbol: RPS9
1 Cross references
239 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSEBUG00000006151
Gene Symbol: RPLP1
1 Cross references
392 Possible Orthologues:

Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSEBUG00000014193
Gene Symbol: SERPINC1
1 Cross references
202 Possible Orthologues:

Si:dkey-91m11.5

Ensembl ID : ENSEBUG00000014493
Gene Symbol: SI:DKEY-91M11.5
1 Cross references
286 Possible Orthologues:

Solute Carrier Family 18 Member 2

Ensembl ID : ENSEBUG00000006911
Gene Symbol: SLC18A2
1 Cross references
225 Possible Orthologues:

Solute Carrier Family 5 Member 1

Ensembl ID : ENSEBUG00000015829
Gene Symbol: SLC5A1
1 Cross references
249 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSEBUG00000009785
Gene Symbol: SLC6A9
1 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSEBUG00000004408
Gene Symbol: SLC9A3
1 Cross references
238 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSEBUG00000010246
Gene Symbol: SSTR4
1 Cross references
252 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSEBUG00000001758
Gene Symbol: SSTR5
1 Cross references
260 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).